Ligand id: 9957

Name: artenimol

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 0
Topological polar surface area 57.15
Molecular weight 284.16
XLogP 2.81
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

No information available.
Summary of Clinical Use
Artenimol is approved by the EMA for use in the treatment of malaria, only as part of an artemisinin-based combination therapy (ACT) with piperaquine (trade name Eurartesim®). The FDA granted Orphan Drug designation for Eurartesim® in 2007 for the treatment of uncomplicated malaria (link to FDA Orphan Drug Designation record here).
The link to extended ADME data provided below is for the combined formulation with piperaquine.
External links